TC
HRTX icon

Tejara Capital’s Heron Therapeutics HRTX Stock Holding History

Tejara Capital’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.07M Buy
6,336,755
+1,205,329
+23% +$1.4M 1.67% 16
2025
Q4 		$6.67M Buy
5,131,426
+541,711
+12% +$669K 2.77% 12
2025
Q3 		$5.78M Buy
4,589,715
+72,300
+2% +$115K 3.17% 10
2025
Q2 		$9.35M Sell
4,517,415
-59,992
-1% -$123K 4.34% 3
2025
Q1 		$10.1M Sell
4,577,407
-84,140
-2% -$163K 4.96% 3
2024
Q4 		$7.13M Sell
4,661,547
-644,269
-12% -$1.04M 4.67% 8
2024
Q3 		$10.6M Buy
5,305,816
+1,117,956
+27% +$2.67M 5.04% 4
2024
Q2 		$14.7M Sell
4,187,860
-223,707
-5% -$687K 5.34% 2
2024
Q1 		$12.2M Sell
4,411,567
-863,669
-16% -$2.17M 4.53% 3
2023
Q4 		$8.97M Buy
5,275,236
+3,165,555
+150% +$3.49M 3.76% 9
2023
Q3 		$2.17M Buy
2,109,681
+469,548
+29% +$668K 1.24% 25
2023
Q2 		$1.9M Sell
1,640,133
-27,386
-2% -$48.8K 0.94% 31
2023
Q1 		$2.52M Buy
1,667,519
+1,173,900
+238% +$2.94M 1.29% 26
2022
Q4 		$1.23M Buy
+493,619
New +$1.59M 0.72% 39

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.29B AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
CPC
Congress Park Capital Saratoga Springs, New York $326M AUM 16.2% 1-Year Est. Return